Atrial Fibrillation


  • Atrial fibrillation (AF) is the most common sustained abnormal heart rhythm. If left untreated AF is a significant risk factor for stroke and other morbidities.

    Load more

    Atrial fibrillation (AF) is the most common sustained type of cardiac arrhythmia, characterised by irregularly irregular ventricular pulse and loss of association between the cardiac apex beat and radial pulsation.

    Evidence suggests an increasing prevalence and incidence worldwide, currently affecting 0.5% of the world’s population.The risk of AF increases with age, particularly after age 60,affecting roughly one in every 10 people 80 years and older according to the CDC.

    AF may be either occasional, persistent or permanent. With occasional AF, symptoms come and go; this type of AF is called paroxysmal AF. As a first step in diagnosis, an electrocardiogram (ECG) should be performedin all patients with suspected AF following an irregular pulse. An ECG is diagnostic except in paroxysmal AF between attacks.

    The evaluation of AF involves uncovering the cause of the arrhythmia. Diagnostic investigation typically includes a complete history, physical examination, ECG, transthoracic echocardiogram, complete blood count, and serum thyroid stimulating hormone level. Some may also benefit from an in-depth evaluation that may include correlation of the heart rate response to exercise, exercise stress testing, chest X-ray, transesophageal echocardiography, and other studies.

    In people with suspected paroxysmal AF undetected by standard ECG recording, a 24-hour ambulatory ECG monitor can be used for those with suspected asymptomatic episodes or symptomatic episodes less than 24 hours apart and an event recorder ECG for those with symptomatic episodes more than 24 hours apart.

    Whilst AF can feel unusual and frightening for some patients, others experience no symptoms. Either way, it doesn’t usually have harmful consequences. The real danger is the increased risk of strokeand related heart problems. Symptoms can range from palpitations, weakness, fatigue, reduced ability to exercise, lightheadedness, dizziness, confusion, shortness of breath and chest pain.

    Sometimes the cause of AF is unknown. In other instances, the cause is damage to the heart's electrical system from conditions such as longstanding, uncontrolled high blood pressure or artery disease, chronic lung disease, cardiomyopathy orcongential heart disease. AF is also the most common complication after heart surgery.

    Less common causes of AF include hyperthyroidism, pericarditis and viral infection. In at least 10% of people with AF, no underlying heart disease is found although in many of these cases, AF may be related to alcohol or excessive caffeine, stress, certain drugs, electrolyte or metabolic imbalances, or severe infections. In some people, no cause can be found.

    Management of AF involves control of the arrhythmia (by rhythm or rate control) and thromboprophylaxis to prevent strokes.

    Any underlying cause such as acute infection or,hyperthyroidism needs to be treated as well as any associated heart failure.

    Options available to treat AF includelifestyle changes, medication, certain medical procedures and surgery. The choice of treatment is based on heart rate and symptoms. Rate control is the first-line strategy. When medications do not work or are not tolerated, a procedure may be necessary, such as electrical cardioversion, pulmonary vein isolation ablation, catheter ablation of the AV node with a pacemaker, or device therapy.

    Load Less

Editor's choice




The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications

Catheter ablation is an effective strategy to maintain sinus rhythm in patients with symptomatic atrial fibrillation (AF), which has evolved from a highly specialised technique to a first-line therapy.1–3 The cornerstone of ablation is pulmonary vein isolation (PVI).4 Over the last decade, ablation devices have undergone technical improvements, aiming for better lesion durability and ablation outcomes.

Source Determination in Atrial Fibrillation

Catheter ablation of AF has shown steady growth over the past two decades with a nearly 15 % annual increase in the US.1 This growth can be attributed in large part to four factors: an increase in operators and institutions performing the procedure;2 a steady rise in AF prevalence, which is predicted to reach 12 million in the US by 2030;3 a larger spectrum of AF patients with more complex atrial substrates being offered ablation;

Risk Factor Management in Atrial Fibrillation

Atrial fibrillation (AF) is the most common clinical arrhythmia worldwide and is expected to increase in the coming decades.1,2 It currently affects up to 3 % of Western populations aged 20 years or older, and the number of affected individuals in the EU will increase from about 7 million to almost 13 million by 2030.3–5 This growing epidemic is not only caused by the natural ageing of the population, but also by the accumulation of chronic cardiovascular diseases and risk factors,